Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses (Q42937380)
scientific article published on 5 April 2012
Language:
(P31) (Q13442814)
(P50) (Q37838558)
(P304) 255-261
(P407) (Q1860)
(P433) 3
(P478) 20
(P577) Thursday, April 5, 2012
(P921) (Q1560099)
(P1433) (Q15763095)
(P1476) "Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses" (language: en)
(P2093) K-W Peng
R Myers
A Greenslade
E Mader
S Greiner
M J Federspiel
S J Russell
(P2860) (Q37915679)
(Q35238258)
(Q34187201)
(Q37808232)
(Q42080758)
(Q37719625)
(Q33930081)
(Q24628227)
(Q39863254)
(Q37099738)
(Q36221386)
(Q33813146)
(Q42063211)
(Q24647228)
(Q36850878)
(Q36720873)
(Q35036505)
(Q27473287)
(Q40371543)
(Q33675567)
(Q34275294)
(Q35182301)
(Q35131235)
(Q33804845)
(Q39588293)
(Q33724190)
(Q36268223)
(Q45869559)
(Q43583253)
(Q43941683)
(Q45222437)
(Q71766274)
(Q78562134)
(Q78029156)
other details
description scientific article published on 5 April 2012

External Links